We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





MEDICA 2021 + COMPAMED 2021 Far Exceed Expectations and Achieve Extremely Successful Results

By LabMedica International staff writers
Posted on 19 Nov 2021

After their four-day run as an in-person event, MEDICA and COMPAMED achieved extremely successful results in Düsseldorf, Germany. More...

From 15 to 18 November 2021, the world’s leading information and communication platforms for the medical technology industry and its supplier sector presented a wealth of convincing innovations as well as accompanying programs that covered a wide range of topics (supplemented by digital offers) and did justice to their internationally prestigious position. 46,000 visitors (with an international share of 73%) from 150 countries seized the opportunity to engage in person with the 3,033 MEDICA and 490 COMPAMED exhibitors in Düsseldorf, obtaining information on the comprehensive range of innovations for outpatient and inpatient care, including every step of their development and manufacture, and trying out many innovative products live in the trade fair halls.

The industry portals MEDICA.de and COMPAMED.de added a range of offers in line with the live events at the trade fairs. This allowed users to access livestreams to watch the stage programs of all expert forums that had been integrated into the trade fairs as well as the 44th German Hospital Conference and the MEDICA MEDICINE + SPORTS CONFERENCE; network via the special Matchmaking tool; and obtain information on innovative products in the exhibitors’ online showrooms.

As expected, COVID-19 and the findings gained to date while managing the pandemic with regard to the implementation of new therapeutic approaches and care concepts were recurring themes in many talks at the forums and accompanying conferences. The MEDICA MEDICINE + SPORTS CONFERENCE, for example, took a closer look at how to get back into sports after suffering from long COVID, while the MEDICA ECON FORUM and the MEDICA HEALTH IT FORUM focused on digitizing processes in the healthcare system.

In line with these themes, exhibitors offered many innovations for the clinical and outpatient field. And the young start-up scene was heavily involved as well, something that was impressively proven during the thrilling pitch competitions held as part of the 10th MEDICA Startup COMPETITION and the 13th Healthcare Innovation World Cup, which took place on the MEDICA CONNECTED HEALTHCARE FORUM program stage. The 13th Healthcare Innovation World Cup focused on innovative devices and smart applications for digital networking and process integration, with an eye to the Internet of Medical Things. From among 300 entries, the jury selected 12 start-ups for the finals on 15 November. Ideas ranged from artificial intelligence (AI) and health apps to robotics at the 10th MEDICA Startup COMPETITION (on 16 November).

Trends along the entire process chain of medical technological manufacture and product developments dominated both the trade fair business of exhibitors and visitors at COMPAMED (which took place in Halls 13 and 14 this time around) and the stage programs of the two integrated expert forums. Innovative substances played just as great a role as innovative, printed electronics, smart sensor solutions and microfluidic options to resolve challenges in point of care diagnostics.

“The atmosphere in the trade fair halls was relaxed and characterised by a sense of optimism throughout; conversations with our customers have shown that in many cases, we have exceeded expectations. People were finally able to establish new and intensify existing contacts in person,” said Erhard Wienkamp, Managing Director of Messe Düsseldorf.

“The numbers are encouraging, and were hardly expected to be at this level in spring. With the combination of trade fair events and digital supplements, MEDICA and COMPAMED have given the industry strong stimuli. The exhibitors are happy to have come to Düsseldorf and are already actively inquiring about options to take part next year,” added Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf, thus reflecting the positive signals fed back by participants and trade associations alike.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Illustration of CNF-sheet-mediated membrane fusion between an extracellular vesicle and a lipid nanoparticle carrying molecular beacons for internal microRNA detection. (Image Credit: Kawaguchi et al., Cell Reports Physical Science, 2026. DOI: 10.1016/j.xcrp.2026.103613)

Single-Vesicle Analysis Reveals Tissue-Associated Inflammatory Signatures

Chronic inflammation can persist for months or years when immune cells continue attacking tissues despite the absence of an active threat. It is associated with cancers, brain disorders, autoimmune diseases,... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

Patients with solid tumors often undergo molecular profiling to identify alterations that can guide therapy. This testing may also reveal constitutional cancer-predisposing DNA variants, which are present... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.